HAVN Life Sciences Inc. (HAVLF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0018 (-94.74%)
At close: Dec 29, 2025
HAVN Life Sciences Market Cap
HAVN Life Sciences has a market cap or net worth of $621.26 thousand as of February 12, 2026. Its market cap has decreased by -91.30% in one year.
Market Cap
621.26K
Enterprise Value
630.11K
Revenue
440.11K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 8, 2020, HAVN Life Sciences's market cap has decreased from 30.90M to 621.26K, a decrease of -97.99%. That is a compound annual growth rate of -70.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2023 | 621.26K | -28.86% |
| Dec 30, 2022 | 873.31K | -94.89% |
| Dec 31, 2021 | 17.10M | -71.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagenic Therapeutics | 732.60K |
| Altamira Therapeutics | 718.01K |
| Aibotics | 717.45K |
| SQZ Biotechnologies Company | 707.79K |
| Sorrento Therapeutics | 706.83K |
| Avenue Therapeutics | 631.21K |
| Bio-Path Holdings | 609.98K |
| Helix BioMedix | 606.71K |